These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4020838)

  • 21. Monkey liver cytochrome P450 2C19 is involved in R- and S-warfarin 7-hydroxylation.
    Hosoi Y; Uno Y; Murayama N; Fujino H; Shukuya M; Iwasaki K; Shimizu M; Utoh M; Yamazaki H
    Biochem Pharmacol; 2012 Dec; 84(12):1691-5. PubMed ID: 23041648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation.
    Pearce R; Greenway D; Parkinson A
    Arch Biochem Biophys; 1992 Oct; 298(1):211-25. PubMed ID: 1381906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of rabbit hepatic microsomal cytochrome P-450 by imidazole: enhanced metabolic activity and altered substrate specificity.
    Kaul KL; Novak RF
    Arch Biochem Biophys; 1984 Dec; 235(2):470-81. PubMed ID: 6517600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P-450 isozyme/isozyme functional interactions and NADPH-cytochrome P-450 reductase concentrations as factors in microsomal metabolism of warfarin.
    Kaminsky LS; Guengerich FP
    Eur J Biochem; 1985 Jun; 149(3):479-89. PubMed ID: 3924614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.
    Yamazaki H; Shimada T
    Arch Biochem Biophys; 1997 Oct; 346(1):161-9. PubMed ID: 9328296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regioselectivity of cytochrome P-450 catalyzed hydroxylation of fluorobenzenes predicted by calculated frontier orbital substrate characteristics.
    Rietjens IM; Soffers AE; Veeger C; Vervoort J
    Biochemistry; 1993 May; 32(18):4801-12. PubMed ID: 8490024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P-450-catalyzed desaturation of valproic acid in vitro. Species differences, induction effects, and mechanistic studies.
    Rettie AE; Boberg M; Rettenmeier AW; Baillie TA
    J Biol Chem; 1988 Sep; 263(27):13733-8. PubMed ID: 3138238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of enzyme induction on the stereoselective metabolism of optically pure (-)1R,2R- and (+)1S,2S-dihydroxy-1,2-dihydrobenz-[a]anthracenes to vicinal 1,2-dihydrodiol 3,4-epoxides by rat liver microsomes.
    Chou MW; Chiu PL; Fu PP; Yang SK
    Carcinogenesis; 1983; 4(5):629-38. PubMed ID: 6850995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers.
    Yamazaki H; Shimada T
    Biochem Pharmacol; 1997 Dec; 54(11):1195-203. PubMed ID: 9416970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new warfarin metabolite: structure and function.
    Fasco MJ; Dymerski PP; Wos JD; Kaminsky LS
    J Med Chem; 1978 Oct; 21(10):1054-9. PubMed ID: 722713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for the stability and cytochrome P450 specificity of the phenobarbital-induced reductive halothane-cytochrome P450 complex formed in rat hepatic microsomes.
    Baker MT; Vasquez MT; Chiang CK
    Biochem Pharmacol; 1991 Jun; 41(11):1691-9. PubMed ID: 2043158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study on the regioselectivity and mechanism of the aromatic hydroxylation of monofluoroanilines.
    Cnubben NH; Vervoort J; Veeger C; Rietjens IM
    Chem Biol Interact; 1992 Dec; 85(2-3):151-72. PubMed ID: 1493607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible inhibition of aromatic hydroxylation of methamphetamine in rat liver microsomal preparations pretreated with methamphetamine.
    Yamamoto T; Takano R; Egashira T; Yamanaka Y
    Biochem Pharmacol; 1988 Apr; 37(8):1433-7. PubMed ID: 3358776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of steroid 5 alpha-reductase and its effects on testosterone hydroxylation by rat liver microsomal cytochrome P-450.
    Sonderfan AJ; Parkinson A
    Arch Biochem Biophys; 1988 Aug; 265(1):208-18. PubMed ID: 3415243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative liquid chromatography/mass spectrometry/mass spectrometry warfarin assay for in vitro cytochrome P450 studies.
    Zhang ZY; King BM; Wong YN
    Anal Biochem; 2001 Nov; 298(1):40-9. PubMed ID: 11673893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin.
    Kaminsky LS; Dunbar DA; Wang PP; Beaune P; Larrey D; Guengerich FP; Schnellmann RG; Sipes IG
    Drug Metab Dispos; 1984; 12(4):470-7. PubMed ID: 6148215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the substrate specificity of cytochrome P450IIIA1.
    Namkung MJ; Yang HL; Hulla JE; Juchau MR
    Mol Pharmacol; 1988 Nov; 34(5):628-37. PubMed ID: 3264050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chiral sulfoxidations catalyzed by rat liver cytochromes P-450.
    Waxman DJ; Light DR; Walsh C
    Biochemistry; 1982 May; 21(10):2499-507. PubMed ID: 7093200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1-Ethynylpyrene, a suicide inhibitor of cytochrome P-450 dependent benzo[a]pyrene hydroxylase activity in liver microsomes.
    Gan LS; Acebo AL; Alworth WL
    Biochemistry; 1984 Aug; 23(17):3827-36. PubMed ID: 6487578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.